{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:17:28Z","timestamp":1763036248718},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11910-006-0020-0","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T15:07:13Z","timestamp":1180105633000},"page":"287-294","source":"Crossref","is-referenced-by-count":17,"title":["PARK8 LRRK2 parkinsonism"],"prefix":"10.1007","volume":"6","author":[{"given":"Kristoffer","family":"Haugarvoll","sequence":"first","affiliation":[]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, et al.: Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112.","journal-title":"Lancet"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C: A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 2005, 20:1255.","journal-title":"Mov Disord"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"J Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C: A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 2005, 34:561.","journal-title":"Age Ageing"},{"key":"20_CR4","first-page":"S21","volume":"54","author":"MC Rijk de","year":"2000","unstructured":"de RijkMC, Launer LJ, Berger K, et al.: Prevalence of Parkinson\u2019s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54:S21.","journal-title":"Neurology"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG, et al.: Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1999, 67:492.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH: Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 2006, 5:235. A review of the nonmotor complications in PD.","journal-title":"Lancet Neurol"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, et al.: Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 2003, 24:197.","journal-title":"Neurobiol Aging"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","volume":"18","author":"T Gasser","year":"2005","unstructured":"Gasser T: Genetics of Parkinson\u2019s disease. Curr Opin Neurol 2005, 18:363. Review of genes involved in parkinsonism.","journal-title":"Curr Opin Neurol"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11910-005-0064-6","volume":"5","author":"AJ Lewthwaite","year":"2005","unstructured":"Lewthwaite AJ, Nicholl DJ: Genetics of parkinsonism. Curr Neurol Neurosci Rep 2005, 5:397. Review of genes involved in parkinsonism.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, et al.: A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002, 51:296. The first article establishing linkage to the PARK8 locus.","journal-title":"Ann Neurol"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","volume":"74","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Muller-Myhsok B, Farrer M, et al.: The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004, 74:11.","journal-title":"Am J Hum Genet"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.20391","volume":"57","author":"C Paisan-Ruiz","year":"2005","unstructured":"Paisan-Ruiz C, Saenz A, Lopez de Munain A, et al.: Familial Parkinson\u2019s disease: clinical and genetic analysis of four Basque families. Ann Neurol 2005, 57:365.","journal-title":"Ann Neurol"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, et al.: Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology. Neuron 2004, 44:601. One of the to back-to-back papers describing LRRK2 as the gene causing autosomal dominant PD linked to PARK8.","journal-title":"Neuron"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, et al.: Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 2004, 44:595. The other back-to-back paper describing LRRK2 as the gene causing autosomal dominant PD linked to PARK8.","journal-title":"Neuron"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.20456","volume":"57","author":"JO Aasly","year":"2005","unstructured":"Aasly JO, Toft M, Fernandez-Mata I, et al.: Clinical features of LRRK2-associated Parkinson\u2019s disease in central Norway. Ann Neurol 2005, 57:762. One of the early clinical descriptions of Lrrk2 G2019S substitution carriers.","journal-title":"Ann Neurol"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2005.10.083","volume":"395","author":"J Infante","year":"2006","unstructured":"Infante J, Rodriguez E, Combarros O, et al.: LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson\u2019s disease. Neurosci Lett 2006, 395:224\u2013226.","journal-title":"Neurosci Lett"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","volume":"354","author":"S Lesage","year":"2006","unstructured":"Lesage S, Durr A, Tazir M, et al.: LRRK2 G2019S as a cause of Parkinson\u2019s disease in North African Arabs. N Engl J Med 2006, 354:422. One of the first reports on very high frequencies of G2019S in North African Arabs.","journal-title":"N Engl J Med"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.ejhg.5201539","volume":"14","author":"Fonzo A Di","year":"2006","unstructured":"Di Fonzo A, Tassorelli C, De Mari M, et al.: Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson\u2019s disease. Eur J Hum Genet 2006, 14:322\u2013331.","journal-title":"Eur J Hum Genet"},{"key":"20_CR19","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM, Gandhi S, et al.: A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet 2005, 365:415.","journal-title":"Lancet"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/429256","volume":"76","author":"J Kachergus","year":"2005","unstructured":"Kachergus J, Mata IF, Hulihan M, et al.: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005, 76:672. One of the first reports identifying the G2019S substitution and describing a common haplotype that indicates a common founder of the G2019S substitution.","journal-title":"Am J Hum Genet"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.20819","volume":"59","author":"WR Galpern","year":"2006","unstructured":"Galpern WR, Lang AE: Interface between tauopathies and synucleinopathies: A tale of two proteins. Ann Neurol 2006, 59:449.","journal-title":"Ann Neurol"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbamcr.2003.08.008","volume":"1643","author":"L Bosgraaf","year":"2003","unstructured":"Bosgraaf L, Van HaastertPJ: Roc, a Ras\/GTPase domain in complex proteins. Biochim Biophys Acta 2003; 1643:5.","journal-title":"Biochim Biophys Acta"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama M, Hasegawa K, Ohta E, et al.: An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005, 57:918.","journal-title":"Ann Neurol"},{"key":"20_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","volume":"6","author":"IF Mata","year":"2005","unstructured":"Mata IF, Kachergus JM, Taylor JP, et al.: Lrrk2 pathogenic substitutions in Parkinson\u2019s disease. Neurogenetics 2005, 6:171.","journal-title":"Neurogenetics"},{"key":"20_CR25","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/brain\/awh667","volume":"128","author":"NL Khan","year":"2005","unstructured":"Khan NL, Jain S, Lynch JM, et al.: Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson\u2019s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128:2786. This report includes PET findings associated with LRRK2 mutations.","journal-title":"Brain"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/01.wnl.0000180517.70572.37","volume":"65","author":"L Skipper","year":"2005","unstructured":"Skipper L, Shen H, Chua E, et al.: Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 2005, 65:1319.","journal-title":"Neurology"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/01.WNL.0000167552.79769.b3","volume":"65","author":"C Paisan-Ruiz","year":"2005","unstructured":"Paisan-Ruiz C, Lang AE, Kawarai T, et al.: LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 2005, 65:696.","journal-title":"Neurology"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/01.WNL.0000172630.22804.73","volume":"65","author":"CP Zabetian","year":"2005","unstructured":"Zabetian CP, Samii A, Mosley AD, et al.: A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005, 65:741.","journal-title":"Neurology"},{"key":"20_CR29","doi-asserted-by":"crossref","unstructured":"Tomiyama H, Li Y, Funayama M, et al.: Clinicogenetic study of mutations ini LRRK2 exon 41 in Parkinson\u2019s disease patients from 18 countries. Mov Disord 2006, [e-pub ahead of print].","DOI":"10.1002\/mds.20886"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20664","volume":"58","author":"S Biskup","year":"2005","unstructured":"Biskup S, Mueller JC, Sharma M, et al.: Common variants of LRRK2 are not associated with sporadic Parkinson\u2019s disease. Ann Neurol 2005, 58:905. A comprehensive evaluation of common variants within the LRRK2 gene.","journal-title":"Ann Neurol"},{"key":"20_CR31","first-page":"e09","volume":"43","author":"C Paisan-Ruiz","year":"2006","unstructured":"Paisan-Ruiz C, Evans EW, Jain S, et al.: Testing association between LRRK2 and Parkinson\u2019s disease and investigating linkage disequilibrium 10.1136\/jmg.2005.036889. J Med Genet 2006, 43:e09.","journal-title":"J Med Genet"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1093\/hmg\/ddi376","volume":"14","author":"L Skipper","year":"2005","unstructured":"Skipper L, Li Y, Bonnard C, et al.: Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson\u2019s disease. Hum Mol Genet 2005, 14:3549.","journal-title":"Hum Mol Genet"},{"key":"20_CR33","first-page":"412","volume":"365","author":"Fonzo A Di","year":"2005","unstructured":"Di Fonzo A, Rohe CF, Ferreira J, et al.: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson\u2019s disease. Lancet 2005, 365:412.","journal-title":"Lancet"},{"key":"20_CR34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/01.WNL.0000169023.51764.b0","volume":"65","author":"M Farrer","year":"2005","unstructured":"Farrer M, Stone J, Mata IF, et al.: LRRK2 mutations in Parkinson disease. Neurology 2005, 65:738.","journal-title":"Neurology"},{"key":"20_CR35","first-page":"410","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols WC, Pankratz N, Hernandez D, et al.: Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease. Lancet 2005, 365:410.","journal-title":"Lancet"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.20618","volume":"20","author":"DM Kay","year":"2005","unstructured":"Kay DM, Zabetian CP, Factor SA, et al.: Parkinson\u2019s disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics. Mov Disord 2005, 20:1077\u20131078.","journal-title":"Mov Disord"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neulet.2005.04.103","volume":"384","author":"EK Tan","year":"2005","unstructured":"Tan EK, Shen H, Tan LC, et al.: The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson\u2019s disease patients. Neurosci Lett 2005, 384:327.","journal-title":"Neurosci Lett"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.parkreldis.2005.09.003","volume":"11","author":"CS Lu","year":"2005","unstructured":"Lu CS, Simons EJ, Wu-Chou YH, et al.: The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord 2005, 11:521.","journal-title":"Parkinsonism Relat Disord"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, et al.: LRRK2 G2019S as a cause of Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 2006; 354:424. Reporting very high frequencies of G2019S in Ashkenazi Jews.","journal-title":"N Engl J Med"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1468-1331.2006.01256.x","volume":"13","author":"IF Mata","year":"2006","unstructured":"Mata IF, Ross OA, Kachergus J, et al.: LRRK2 mutations are a common cause of Parkinson\u2019s disease in Spain. Eur J Neurol 2006, 13:391\u2013394.","journal-title":"Eur J Neurol"},{"key":"20_CR41","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.20682","volume":"20","author":"JM Bras","year":"2005","unstructured":"Bras JM, Guerreiro RJ, Ribeiro MH, et al.: G2019S dardarin substitution is a common cause of Parkinson\u2019s disease in a Portuguese cohort. Mov Disord 2005, 20:1653.","journal-title":"Mov Disord"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/432422","volume":"77","author":"S Lesage","year":"2005","unstructured":"Lesage S, Leutenegger AL, Ibanez P, et al.: LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 2005, 77:330.","journal-title":"Am J Hum Genet"},{"key":"20_CR43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neulet.2005.03.033","volume":"382","author":"IF Mata","year":"2005","unstructured":"Mata IF, Taylor JP, Kachergus J, et al.: LRRK2 R1441G in Spanish patients with Parkinson\u2019s disease. Neurosci Lett 2005, 382:309.","journal-title":"Neurosci Lett"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","volume":"62","author":"ZK Wszolek","year":"2004","unstructured":"Wszolek ZK, Pfeiffer RF, Tsuboi Y, et al.: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004, 62:1619.","journal-title":"Neurology"},{"key":"20_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1353-8020(97)00013-8","volume":"3","author":"ZK Wszolek","year":"1997","unstructured":"Wszolek ZK, Vieregge P, Uitti RJ, et al.: German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia: longitudinal observations. Parkinsonism Relat Disord 1997, 3:125.","journal-title":"Parkinsonism Relat Disord"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","volume":"59","author":"OA Ross","year":"2006","unstructured":"Ross OA, Toft M, Whittle AJ, et al.: Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388. A report on pathologic features in G2019S substitution carriers.","journal-title":"Ann Neurol"},{"key":"20_CR47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, et al.: Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006, 59:315.","journal-title":"Ann Neurol"},{"key":"20_CR48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.20401","volume":"57","author":"DG Hernandez","year":"2005","unstructured":"Hernandez DG, Paisan-Ruiz C, McInerney-Leo A, et al.: Clinical and positron emission tomography of Parkinson\u2019s disease caused by LRRK2. Ann Neurol 2005, 57:453. Clinical and PET features of LRRK2.","journal-title":"Ann Neurol"},{"key":"20_CR49","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","volume":"128","author":"JR Adams","year":"2005","unstructured":"Adams JR, van Netten H, Schulzer M, et al.: PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation. Brain 2005, 128:2777. PET findings in LRRK2 mutation carriers, including evidence of presymptomatic compensation in mutation carriers.","journal-title":"Brain"},{"key":"20_CR50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.mad.2005.06.010","volume":"126","author":"M Toft","year":"2005","unstructured":"Toft M, Sando SB, Melquist S, et al.: LRRK2 mutations are not common in Alzheimer\u2019s disease. Mech Ageing Dev 2005, 126:1201.","journal-title":"Mech Ageing Dev"},{"key":"20_CR51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/archneur.63.1.156","volume":"63","author":"CP Zabetian","year":"2006","unstructured":"Zabetian CP, Lauricella CJ, Tsuang DW, et al.: Analysis of the LRRK2 G2019S mutation in Alzheimer Disease. Arch Neurol 2006, 63:156.","journal-title":"Arch Neurol"},{"key":"20_CR52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2990.2006.00693.x","volume":"32","author":"OA Ross","year":"2006","unstructured":"Ross OA, Whittle AJ, Cobb SA, et al.: Lrrk2 R1441 substitution and progressive supranuclear palsy. Neuropathol Appl Neurobiol 2006, 32:23.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"20_CR53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.20618","volume":"20","author":"DM Kay","year":"2005","unstructured":"Kay DM, Kramer P, Higgins D, et al.: Escaping Parkinson\u2019s disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Mov Disord 2005, 20:1077.","journal-title":"Mov Disord"},{"key":"20_CR54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","volume":"15","author":"CJ Gloeckner","year":"2006","unstructured":"Gloeckner CJ, Kinkl N, Schumacher A, et al.: The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006; 15:223. One of the initial reports on functional research on LRRK2 mutations.","journal-title":"Hum Mol Genet"},{"key":"20_CR55","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S, et al.: Parkinson\u2019s diseaseassociated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 2005, 102:16842. The first report showing that the LRRK2 mutations enhance kinase activity.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.20390","volume":"20","author":"RM Silva","year":"2005","unstructured":"Silva RM, Kuan CY, Rakic P, Burke RE: Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson\u2019s disease. Mov Disord 2005, 20:653.","journal-title":"Mov Disord"},{"key":"20_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.07.045","volume":"390","author":"M Bialecka","year":"2005","unstructured":"Bialecka M, Hui S, Klodowska-Duda G, et al.: Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson\u2019s disease. Neurosci Lett 2005, 390:1.","journal-title":"Neurosci Lett"},{"key":"20_CR58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.parkreldis.2005.05.004","volume":"11","author":"D Gosal","year":"2005","unstructured":"Gosal D, Ross OA, Wiley J, et al.: Clinical traits of LRRK2-associated Parkinson\u2019s disease in Ireland: a link between familial and idiopathic PD. Parkinsonism Relat Disord 2005, 11:349.","journal-title":"Parkinsonism Relat Disord"},{"key":"20_CR59","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1136\/jmg.2005.035568","volume":"42","author":"S Goldwurm","year":"2005","unstructured":"Goldwurm S, Di Fonzo A, Simons EJ, et al.: The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson\u2019s disease and originates from a common ancestor. J Med Genet 2005, 42:e65.","journal-title":"J Med Genet"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-006-0020-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-006-0020-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-006-0020-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:35Z","timestamp":1559435075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-006-0020-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11910-006-0020-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}